A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer

Published:2014-05 Issue:5 Volume:9 Page:710-716
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Dingemans Anne-Marie C.,Bootsma Gerben,van Baardwijk Angela,Reymen Bart,Wanders Rinus,Brans Boudewijn,Das Marco,Hochstenbag Monique,van Belle Arne,Houben Ruud,Lambin Philippe,de Ruysscher Dirk

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study;De Ruysscher;Ann Oncol,2009

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Non-small-cell lung cancer;Goldstraw;Lancet,2011

4. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma;Machtay;J Thorac Oncol,2012

5. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial;Albain;Lancet,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long Intergenic Non-Protein Coding RNA 173 in Human Cancers;Cancers;2022-11-30

2. Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis;Future Oncology;2022-09

3. LINC00963: A potential cancer diagnostic and therapeutic target;Biomedicine & Pharmacotherapy;2022-06

4. Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience;Brachytherapy;2019-11

5. Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study;Radiotherapy and Oncology;2019-06